Veillonella parvula was found to modulate host immune responses in the lower airways, leading to reduced survival, increased tumor burden, an interleukin-17 (IL-17) inflammatory phenotype, and the activation of checkpoint inhibitor markers in KP lung cancer mice (Tsay et al, 2021). The gene discussed is IL17A; the disease is neoplasm.